Once known by the former name of Zep Bound, Zepbound is a groundbreaking formula invented and manufactured by Eli Lilly Company. This medication is designed for obese and overweight adults with related health problems to assist in weight loss and its prevention. Tirzepatide, the active ingredient, simulates the effects of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, reducing appetite, slowing digestion, and regulating blood sugar levels.
Available Dosage Forms
Zepbound is administered via subcutaneous injection using pre-filled, disposable injector pens. Available strengths include:
- 2.5 mg/0.5 mL
- 5 mg/0.5 mL
- 7.5 mg/0.5 mL
- 10 mg/0.5 mL
- 12.5 mg/0.5 mL
- 15 mg/0.5 mL
Dosing Schedule
The recommended initiation and titration schedule includes:
Starting Dose
2.5 mg once weekly for the first 4 weeks to build tolerance.
Dose Escalation
If tolerated, increase to 5 mg weekly. Doses can be raised by 2.5 mg every 4 weeks if needed.
Maintenance Dose
Recommended doses are 5 mg, 10 mg, or 15 mg weekly, not exceeding 15 mg per week.
Administration Guidelines
- Frequency: Administer once per week on the same day, with or without food.
- Injection Sites: Inject subcutaneously into the abdomen, thigh, or deltoid, rotating sites to minimize side effects.
- Missed Dose: If a dose is missed, take it within 96 hours. Otherwise, skip it and resume the normal schedule.
- Changing Administration Day: Ensure at least 72 hours between doses when changing the weekly schedule.
Storage Instructions
- Refrigeration: Store at 36°F to 46°F (2°C to 8°C).
- Room Temperature: May be stored up to 30°C for no more than 21 days.
- Avoid Freezing: Do not use if frozen or exposed to extreme heat.
- Protection from Light: Keep pens in their original packaging to shield from light.
Lifestyle Considerations
Zepbound is most effective when combined with a reduced-calorie diet and increased physical activity. These lifestyle changes enhance the medication’s positive effects and promote sustainable weight loss.
Healthcare Providers’ Input
Frequent communication with healthcare providers is vital for evaluating effectiveness, adjusting dosing, and ensuring patient safety. With expert guidance, patients can achieve the best outcomes in their weight loss journey.
Semaglutide: A Revolutionary Approach with HealifyNow
At HealifyNow, we prioritize transformative solutions for weight management. Semaglutide, a GLP-1 receptor agonist, regulates appetite, enhances satiety, and improves blood sugar control. Paired with healthy eating and exercise, it offers a sustainable path to a healthier future. Our expert team ensures seamless integration of semaglutide into your weight loss journey.
